Phase 1 trial shows NGM621 for GA is well tolerated by study participants
Investigation evaluates safety of single and multiple intravitreal injections.
Novel ophthalmic pharmaceuticals drive innovation, improve outcomes
Understanding nuances of reimbursement for novel, sustained-release ophthalmic drugs can help maximize the opportunity for patients and practice.
Physicians measure contrast sensitivity in patients with cataract
Advances help gain clearer image, enhancing decision-making process.
Expectations are on rise for presbyopia-correcting therapeutic
Patients can try different drops and dosing schedules to improve outcomes.
Focusing on postinjection endophthalmitis
Systemic immunosuppression may prevent devastating complication in patients.
Addressing GA by downregulating overactive complement system
GT005 designed to induce local production of recombinant complement factor I.
The benefits of cryopreserved amniotic membrane during COVID-19
CAM’s regenerative healing means long-term relief and fewer visits to clinic.
Choroidal hypertransmission defects on en face OCT imaging predict geographic atrophy in patients
Philip Rosenfeld, MD, PhD, presents results from a natural history study of patients that results in recognition of hypertransmission defects on en face OCT.
CRISPR technology: A hot topic in gene therapy
Cotargeted therapy could help combat inherited retinal diseases.
VA and visual function go the way of ocular inflammation
Tool for quantifying measures may predict outcomes for patients.
Bariatric surgery may lead to decreased risk of cataract
Substantial weight loss can help patients’ eye health, study results show.
AAVCOVID vaccine: A combination of factors harnessing COVID-19
The primary barriers to COVID-19 vaccine development are manufacturing constraints.
Pivotal study data drive glaucoma patient treatment decisions
Two trials examine factors affecting the risk of disease.
2 Clarke Drive Cranbury, NJ 08512